Related Experiment Video
Updated: Apr 2, 2026
14:37
High-throughput Synthesis of Carbohydrates and Functionalization of Polyanhydride Nanoparticles
Published on: July 6, 2012
12.0K
Glycan-Based Targeting Technology and Its Application in Therapeutic In Vivo Synthetic Chemistry
Tsung-Che Chang1, Shunya Ohara2, Katsunori Tanaka3,4
1Biofunctional Synthetic Chemistry Laboratory, RIKEN Pioneering Research Institute, Wako, Saitama, Japan.
Advances in Experimental Medicine and Biology
|March 31, 2026
Summary
Researchers developed artificial glycoalbumins to target cancer cells specifically. This approach aims to improve cancer treatment by localizing therapeutic activity and minimizing side effects on healthy tissues.
Area of Science:
- Biochemistry
- Materials Science
- Oncology
Background:
- Chemotherapy has limited specificity, causing side effects.
- Molecularly targeted therapies face challenges due to cancer heterogeneity and limited antigen availability.
- Cell surface glycans mediate cell recognition through specific patterns.
Purpose of the Study:
- To investigate in vivo glycan pattern recognition.
- To develop novel cancer-targeting strategies.
- To create glycosylated therapeutic artificial metalloenzymes for cancer treatment.
Main Methods:
- Creation of artificial glycoalbumins with specific glycan patterns.
- Identification of cancer-specific accumulation patterns for these glycoalbumins.
- Utilizing glycoalbumin scaffolds as therapeutic artificial metalloenzymes.
Main Results:
- Demonstrated cancer-specific accumulation patterns for various glycoalbumins.
- Identified factors influencing glycan pattern recognition in vivo.
- Established glycoalbumin scaffolds for localized therapeutic activity.
Conclusions:
- Artificial glycoalbumins show promise for targeted cancer therapy.
- This approach can potentially reduce side effects by localizing biological activity.
- Foundational research supports the adaptation of glycoalbumin-based targeting for therapeutic applications.
